Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Boxer Capital
268
Boxer Capital
Tavistock Group is an international private investment organization founded by Joe Lewis more than 40 years ago and built on a core philosophy: We strive for excellence in everything we do.
Suggest edits
Follow us
Overview
News
Investments
11
Portfolio
Portfolio Tracker
Add info
$50,000,000
Venture capital (Series A)
FinSMEs
Tyra Biosciences Raises USD 50M in Series A Funding
the home of AI info
Global Superoxide Dismutase [Cu-Zn] Market 2016-2026 | AveXis Inc, Ionis Pharmaceuticals Inc ...
Technical.ly Philly
University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO
PE HUB
VC-backed Cabaletta Bio begins trading on NASDAQ
$113,800,000
IPO
PE HUB
Biopharma firm Atreca goes public
$50,000,000
Venture capital (Series B)
MedCity News
,
FinSMEs
Cabaletta Bio closes $50M Series B round for cell-based autoimmune disease therapies
FinSMEs
Sojournix Completes $44M Series C Financing
$80,000,000
Venture capital
FinSMEs
Milestone Pharmaceuticals Raises $80M in Equity Funding
Funding
Health
$125,000,000
Venture capital (Series C)
FinSMEs
,
PE HUB
,
MedCity News
Atreca Raises $125M in Series C Funding
Funding
Xconomy
SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow
Health
Science
Bloomberg
,
Xconomy
Novartis to Buy AveXis in $8.7 Billion Gene-Therapy Deal
Health
$30,500,000
Venture capital (Series B)
PE HUB
,
FinSMEs
,
Venture Funding News
Poseida Therapeutics snags $30.5 mln Series B
Messaging
$94,000,000
Venture capital (Series B)
FinSMEs
Ideaya Biosciences Raises $94M Crossover Series B Financing
Funding
$75,000,000
Venture capital (Series A)
Xconomy
,
FinSMEs
Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech
Health
Funding
Science
$35,000,000
Venture capital (Series B)
PE HUB
,
PE HUB
Atreca raises $35 mln Series B co-led by Wellington
Funding
$40,000,000
Venture capital (Series A)
prnewswire
CiVi Biopharma Raises $40 Million in Series A Financing From Boxer Capital of the Tavistock Group
$10,000,000
Venture capital (Series C)
VentureWire
,
FinSMEs
Gene Therapy Company AveXis Closes $10M Series C
